111 related articles for article (PubMed ID: 12408703)
1. 1-Benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole (YC-1) derivatives as novel inhibitors against sodium nitroprusside-induced apoptosis.
Lien JC; Lee FY; Huang LJ; Pan SL; Guh JH; Teng CM; Kuo SC
J Med Chem; 2002 Nov; 45(23):4947-9. PubMed ID: 12408703
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
Mol Pharmacol; 2003 Jun; 63(6):1322-8. PubMed ID: 12761342
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the vasorelaxant effects of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft.
Berkan O; Bagcivan I; Kaya T; Yildirim K; Yildirim S; Doğan K
Can J Physiol Pharmacol; 2007 May; 85(5):521-6. PubMed ID: 17632587
[TBL] [Abstract][Full Text] [Related]
4. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells.
Liu XM; Peyton KJ; Mendelev NN; Wang H; Tulis DA; Durante W
Mol Pharmacol; 2009 Jan; 75(1):208-17. PubMed ID: 18923065
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole analogues as novel antiplatelet agents.
Lee FY; Lien JC; Huang LJ; Huang TM; Tsai SC; Teng CM; Wu CC; Cheng FC; Kuo SC
J Med Chem; 2001 Oct; 44(22):3746-9. PubMed ID: 11606139
[TBL] [Abstract][Full Text] [Related]
6. YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats.
Hsieh GC; O'Neill AB; Moreland RB; Sullivan JP; Brioni JD
Eur J Pharmacol; 2003 Jan; 458(1-2):183-9. PubMed ID: 12498924
[TBL] [Abstract][Full Text] [Related]
7. YC-1-like potentiation of NO-dependent activation of soluble guanylate cyclase by derivatives of protoporphyrin IX.
Severina IS; Pyatakova NV; Shchegolev AY; Ponomarev GV
Biochemistry (Mosc); 2006 Mar; 71(3):340-4. PubMed ID: 16545073
[TBL] [Abstract][Full Text] [Related]
8. YC-1 prevents sodium nitroprusside-mediated apoptosis in vascular smooth muscle cells.
Pan SL; Guh JH; Chang YL; Kuo SC; Lee FY; Teng CM
Cardiovasc Res; 2004 Jan; 61(1):152-8. PubMed ID: 14732212
[TBL] [Abstract][Full Text] [Related]
9. The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase.
Hering KW; Artz JD; Pearson WH; Marletta MA
Bioorg Med Chem Lett; 2006 Feb; 16(3):618-21. PubMed ID: 16326101
[TBL] [Abstract][Full Text] [Related]
10. YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cells.
Liu YN; Pan SL; Peng CY; Huang DY; Guh JH; Kuo SC; Lee FY; Teng CM
Shock; 2008 Sep; 30(3):274-9. PubMed ID: 18197143
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
[TBL] [Abstract][Full Text] [Related]
12. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.
Pan SL; Guh JH; Peng CY; Wang SW; Chang YL; Cheng FC; Chang JH; Kuo SC; Lee FY; Teng CM
J Pharmacol Exp Ther; 2005 Jul; 314(1):35-42. PubMed ID: 15784655
[TBL] [Abstract][Full Text] [Related]
13. YC-1 enhances the responsiveness of tolerant vascular smooth muscle to glyceryl trinitrate.
O'Reilly DA; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 2001 Jan; 79(1):43-8. PubMed ID: 11201500
[TBL] [Abstract][Full Text] [Related]
14. Enhanced responsiveness to nitric oxide, nitroxyl anions, and nitrergic transmitter by 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole in the rat anococcygeus muscle.
Che Y; Ellis A; Li CG
Nitric Oxide; 2005 Sep; 13(2):118-24. PubMed ID: 15993633
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: an in vitro and in vivo study.
Wu CH; Chang WC; Chang GY; Kuo SC; Teng CM
J Pharmacol Sci; 2004 Mar; 94(3):252-60. PubMed ID: 15037810
[TBL] [Abstract][Full Text] [Related]
16. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
17. YC-1, an activation inductor of soluble guanylyl cyclase.
Sopková-De Oliveira Santos J; Collot V; Bureau I; Rault S
Acta Crystallogr C; 2000 Aug; 56 ( Pt 8)():1035-6. PubMed ID: 10944319
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
19. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9.
Liu YN; Pan SL; Peng CY; Guh JH; Huang DM; Chang YL; Lin CH; Pai HC; Kuo SC; Lee FY; Teng CM
J Pharmacol Exp Ther; 2006 Jan; 316(1):35-41. PubMed ID: 16183705
[TBL] [Abstract][Full Text] [Related]
20. Combined application of camptothecin and the guanylate cyclase activator YC-1: Impact on cell death and apoptosis-related proteins in ovarian carcinoma cell lines.
Lee SJ; Kim YJ; Lee CS; Bae J
Chem Biol Interact; 2009 Oct; 181(2):185-92. PubMed ID: 19481069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
